Vaping Alarmism vs. Reality: Separating Hype from Science in the Nicotine Debate

https://insightplus.mja.com.au/2026/11/the-impact-of-vape-exposure-on-young-peoples-brains/

Australia’s academics are at it again.

The article tries to paint vaping as a kind of neurological trap designed to hijack the brains of young people. It uses dramatic language, a small laboratory experiment, and several questionable claims to suggest that colourful vape products are almost irresistible and therefore must be tightly restricted. But when you step back and examine the claims more carefully, much of the argument relies on exaggeration, misleading comparisons, and missing context.

The opening paragraph is a good example of how the piece sets the tone. It describes a watermelon-flavoured vape in glowing marketing language before revealing that the product contains nicotine. The intent is clearly rhetorical: the reader is meant to feel that they have been tricked into liking something dangerous. But this kind of framing is not unique to vaping. Every consumer product uses appealing descriptions. Soft drinks promise refreshing flavours, coffee brands talk about rich aromas, and confectionery companies describe sweet indulgence. Presenting flavour descriptions as evidence of manipulation creates a sense of alarm, but it doesn’t actually prove anything about health risk or addiction.

The nicotine comparison used in the article is also misleading. It claims that a vape containing 50 milligrams of nicotine has “around three times the amount in a standard cigarette.” That comparison confuses nicotine concentration with nicotine intake. Vape liquids are labelled in milligrams per millilitre, which describes how concentrated the liquid is, not how much nicotine a person absorbs. Cigarettes themselves contain roughly 10–12 milligrams of nicotine in the tobacco, but smokers only absorb about 1–2 milligrams when they smoke one cigarette. In other words, comparing the nicotine concentration of a bottle of vape liquid with the nicotine absorbed from a cigarette is not an apples-to-apples comparison. It is a common tactic used in anti-vaping commentary because it makes the numbers sound frightening without explaining what they actually mean.

The article also claims that vapes contain toxic chemicals and carcinogens. Technically, that statement can be true, but it is also incomplete in a way that can mislead readers. Many substances can contain trace amounts of chemicals that are harmful at high levels. What matters in toxicology is not simply whether a chemical exists, but how much of it people are exposed to. The key difference between vaping and smoking is that vaping does not involve burning tobacco. Combustion creates thousands of harmful chemicals, including tar and carbon monoxide, which are responsible for most smoking-related diseases such as lung cancer, heart disease, and emphysema. Because vaping heats liquid instead of burning tobacco, the levels of these toxic substances are dramatically lower. That is why numerous health reviews, including those from respected medical bodies, have concluded that vaping is substantially less harmful than smoking.

Another claim repeated in the article is that people who vape are three times more likely to start smoking cigarettes. This statistic is often cited in public debates, but it is widely misunderstood. The studies behind this claim are observational studies, which means they can detect associations but cannot prove cause and effect. Young people who experiment with vaping are often the same individuals who are more likely to experiment with other risky behaviours, including smoking. Researchers refer to this as “common liability” or shared risk factors. When those underlying factors are taken into account, the evidence that vaping causes smoking becomes far weaker than headlines suggest. Presenting the statistic without explaining these limitations gives the impression of a proven causal link when the science is still debated.

The most interesting part of the article is the study itself, but even here, the conclusions are overstated. The researchers used electroencephalography, or EEG, to measure brain activity while participants looked at images of vape products. The study involved just 38 people between the ages of 17 and 23. Participants viewed pictures of vape devices on a screen, and the researchers measured how quickly the brain responded to those images. Now put a chocolate bar in front of them and perform the same test.

The finding was that the brain begins processing the images within a few hundred milliseconds, and that this activity could be linked to how appealing participants later reported the products to be. The authors interpret this as evidence that vape marketing automatically triggers approach tendencies before people have time to think rationally about the product.

But this interpretation is not as groundbreaking as it sounds. Human brains process visual information extremely quickly. Our brains are wired to process visual information extremely fast. Studies show that the brain can extract meaning from images shown in rapid succession up to 75 frames per second, or every 13 milliseconds. It can recognise concepts like a “smiling couple” or a “picnic” almost instantly, without prior exposure. Eye movements happen about three times per second, and while initial recognition is incredibly fast, making decisions or generating a response still takes roughly 250 milliseconds or more. In short, just because the brain notices something quickly doesn’t mean it automatically leads to behaviour or addiction.

The research exaggerates the significance of a millisecond-scale brain reaction and presents it as evidence that vapes are neurologically irresistible. That’s misleading. No demonstration seeing a picture of a vape directly causes someone to pick one up, start vaping, or transition to smoking. In fact, the real-world uptake of vaping among young people is far more complex, involving social context, regulation, peer influence, and education, not milliseconds of brain activity.

In fact, the authors themselves acknowledge that the same type of brain response occurs when people view appealing foods. A colourful picture of a slice of cake can trigger a similar rapid neural reaction. But no one argues that we should ban attractive packaging on desserts because our brains respond to them quickly. The leap from observing a normal brain response to calling for stronger product restrictions is therefore quite a stretch.

Another limitation of the study is the extremely small sample size. Thirty-eight participants are a tiny number for drawing broad conclusions about how young people respond to products in the real world. Laboratory studies can provide interesting insights into how the brain works, but they cannot easily capture the complex social and behavioural factors that influence real decisions. People do not decide whether to vape simply because they saw a colourful image for a few seconds on a screen.

More importantly, the article largely ignores the central public health issue surrounding vaping: its role as a potential alternative to smoking. For decades, smoking has been the leading preventable cause of death in many countries, largely because burning tobacco produces highly toxic smoke. Millions of smokers struggle to quit despite knowing the risks. For some of them, switching to a non-combustible nicotine product such as a vape can significantly reduce their exposure to harmful chemicals.

Countries that take a harm reduction approach to tobacco policy acknowledge this difference. In the United Kingdom, for example, health authorities have stated that vaping is likely to be significantly less harmful than smoking and can help smokers quit. As a result, vaping has been incorporated into smoking cessation strategies in some settings. This does not mean vaping is risk-free, but it recognises that the alternative for many smokers is not a nicotine-free life, but continued cigarette use.

The article does not engage with this harm reduction perspective. Instead, it focuses almost entirely on youth appeal and marketing tactics, portraying vaping as little more than a scheme by the tobacco industry to addict a new generation. While concerns about youth uptake are legitimate, ignoring the potential benefits for adult smokers presents an incomplete picture.

In the end, the study described in the article shows something quite ordinary: that the human brain responds quickly to visually appealing products. That finding applies to almost everything people encounter in modern consumer environments. Using it as evidence that vaping products uniquely manipulate young minds stretches the science far beyond what the data actually show.

Public health policy works best when it carefully weighs both risks and benefits. Smoking remains far more dangerous than vaping because it involves combustion and exposure to thousands of toxic chemicals. A balanced discussion about nicotine products should acknowledge that reality. Lab studies measuring milliseconds of brain activity may make for eye-catching headlines, but they offer limited guidance for policies aimed at reducing smoking-related disease in the real world.